TotalMarketCap

Xtl Biopharmaceuticals

XTLBNasdaq IsraelHealth CareBiotechnology: Pharmaceutical Preparations

Market cap

$4.221 M

$1.72 +0.45%

Close of 6 Nov 2026

As of 6 Nov 2026, Xtl Biopharmaceuticals (XTLB) has a market capitalization of $4.22M. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.

Revenue

—

Not reported

Earnings

—

Not reported

Shares outstanding

946,243,356

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 498 →
  1. #456Xenetic BiosciencesXBIO$4.43M
  2. #457AzitraAZTR$4.43M
  3. #458Xtl BiopharmaceuticalsXTLB$4.22M
  4. #459Apimeds Pharmaceuticals USAPUS$4.05M
  5. #460NuCanaNCNA$3.89M

What if Xtl Biopharmaceuticals were worth as much as…

Open the what-if tool →

Gold $28.2T

$11,490,254

Per share 6,689,326× higher

Bitcoin $1.53T

$621,717.66

Per share 361,948× higher

Apple $5.02T

$2,041,041

Per share 1,188,241× higher

Or at a round number

$10.0M$20.0M$50.0M$100.0M

Where these numbers come from

Share counts and financials for Xtl Biopharmaceuticals are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Read the methodology.